Sunday, January 26, 2020

Biocon Biologics eyes $200M, plans IPO in 2 years: Kiran Mazumdar-Shaw

With the funding, Biocon is looking to fund its research and development, and infuse capital to expand its biosimilars business https://ift.tt/37uXTvM https://ift.tt/eA8V8J

No comments:

Post a Comment

How a Denmark-based research team is using quantum computers to accelerate AI protein discovery, showing a near-term commercial application for the quantum tech (Isabella Ward/Wired)

Isabella Ward / Wired : How a Denmark-based research team is using quantum computers to accelerate AI protein discovery, showing a near-t...